JSJohannes Slotboom

Johannes Slotboom

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Johannes Slotboom has a total of 622 co-authors. Here are the top co-authors by number of shared publications:

  • Roland Wiest

    Institute for Diagnostic and Interventional Neuroradiology, Support Center for Advanced Neuroimaging, University of Bern , 3010 Bern

    9 shared publications
  • Piotr Radojewski

    Institute for Diagnostic and Interventional Neuroradiology, Inselspital, University Hospital and University of Bern, Switzerland; Translational Imaging Center, sitem-insel, Bern, Switzerland

    8 shared publications
  • Roland Kreis

    Magnetic Resonance Methodology, Institute of Diagnostic and Interventional Neuroradiology University of Bern Bern Switzerland

    5 shared publications
  • Guodong Weng

    Institute for Diagnostic and Interventional Neuroradiology, Inselspital, University Hospital and University of Bern, Switzerland; Translational Imaging Center, sitem-insel, Bern, Switzerland

    4 shared publications
  • Raphael Meier

    Support Center for Advanced Neuroimaging, University Institute of Diagnostic and Interventional Neuroradiology, University Hospital Bern, Inselspital, University of Bern, Bern, Switzerland

    4 shared publications
  • Roland Wiest

    Support Center of Advanced Neuroimaging (SCAN), University Institute of Diagnostic and Interventional Neuroradiology, Inselspital, Bern, Switzerland

    4 shared publications

Latest Publications

  • Open Access

    CHEmical-shift selective Adiabatic Pulse (CHEAP): fast and high resolution downfield 3D 1H-MRSI at 7T

    by Guodong Weng, Piotr Radojewski, Sulaiman Sheriff, Arsany Hakim, Irena Zubak, Johannes Kaesmacher, Johannes Slotboom

  • Open Access

    Field strength–dependent sensitivity of chemical exchange saturation transfer: a methodological comparison of 3 Tesla and 7 Tesla in a clinical cohort

    by Milena Capiglioni, Moritz Simon Fabian, Stefanie Marti, Richard McKinley, Robert Hoepner, Alejandro León Betancourt, Johannes Slotboom, Roland Wiest, Moritz Zaiss, Angelika Mennecke, et al.

    Chemical exchange saturation transfer (CEST) MRI provides insight into tissue metabolism by detecting low-concentration endogenous molecules. While studies at 7 Tesla (7T) have shown enhanced sensitivity and spectral separation, 3 Tesla (3T) remains the clinical standard, and the relative performance of these field strengths in a direct clinical head-to-head comparison remains unclear. This prospective cohort study provides a direct within-subject comparison of multi-pool CEST imaging at 3T and 7T, using age-related tissue changes and glioma molecular subtypes as representative applications of physiological and pathological CEST sensitivity. Forty-three patients (ages 18–76; 18 female) underwent 3T and 7T CEST MRI prior to surgery due to suspected brain tumour; following quality control, 36 datasets were included at 3T and 32 at 7T. CEST amplitudes from amide, amine, aliphatic relayed nuclear Overhauser effect (rNOE) and magnetization transfer pools were quantified in white matter, grey matter, deep grey matter and tumour tissue. A physics-informed conditional autoencoder (PICAE) was applied at 7T to correct B1 inhomogeneity. Age effects were tested using linear regression; tumour subtype differences were tested using the Wilcoxon rank-sum test. The significance level was set to α = 0.05, and the Holm–Bonferroni procedure was applied to correct for multiple testing. At 7T, amide and rNOE showed robust negative correlations with age in grey matter and deep grey matter, supporting the potential of CEST as an ageing biomarker. Age dependence at 3T was weaker, limited to rNOE (grey matter and deep grey matter) and magnetization transfer (white matter and deep grey matter). In contrast, tumour CEST metrics showed no significant age dependence at either field strength. Trends in relative amide contrast were consistent with prior findings but did not reach statistical significance. Sensitivity to tumour molecular subtype was similar across field strengths. Variability analyses showed that conventional 7T processing introduced higher technical variability than 3T, whereas PICAE substantially reduced variability and improved data quality at 7T. In conclusion, 7T CEST MRI demonstrates higher potential as a non-invasive marker of brain ageing, whereas our simplified pipeline did not yield additional information for tumour subtyping at either field strength. These findings underscore both the enhanced sensitivity and the higher technical demands of 7T, and highlight the importance of advanced correction strategies such as PICAE for robust use of single-transmit 7T CEST.


  • Open Access

    Accelerated water residual removal in MRS : Exploring deep learning versus fitting‐based approaches

    by Federico Turco, Johannes Slotboom, Milena Capiglioni

    Purpose: Removing water residual signals from MRS spectra is crucial for accurate metabolite quantification. However, currently available algorithms are computationally intensive and time‐consuming, limiting their clinical applicability. This work aims to propose and validate two novel pipelines for fast water residual removal in MRS. Methods: Two methods for water residual removal are proposed and evaluated: DeepWatR and WaterFit. DeepWatR uses a U‐Net‐like architecture with an attention mechanism for skip connections. WaterFit uses Torch auto‐differentiation to estimate parameters for a 7‐pool Lorentzian model. The accuracy and time‐efficiency of these methods were assessed using simulated and in vivo 1H brain datasets and compared with the gold standard, Hankel Lanczos singular value decomposition method (HLSVD)Pro. Results: In the simulated dataset, the average percentage quantification error was % for DeepWatR and % for WaterFit, both comparable to % for HLSVDPro in the main metabolites (Cr, Cho, and NAA). DeepWatR was 51 times faster and WaterFit was 22.7 times faster than HLSVDPro for a dataset of 10 000 voxels when using a low‐end graphics processing unit. For 100 voxels, the speed‐up is 6.5 and 7.5 times faster for DeepWatR and WaterFit, respectively. WaterFit showed higher metabolite fitting accuracy after water removal compared to DeepWatR. Conclusion: WaterFit showed a superior balance of accuracy and processing speed in removing water residual from MRS data compared to DeepWatR. The proposed WaterFit implementation significantly reduces preprocessing time while maintaining metabolite fitting accuracy comparable to gold standard methods. This advancement addresses the need for efficient processing methods that can facilitate analysis and enhance the clinical utility of MRS.

  • Open Access

    Revisiting motor inhibition in individuals with functional paralysis and spinal cord injury

    by Vanessa Vallesi, Cécile Galléa, Jothini Sritharan, Elia R Hurni, Inge Eriks-Hoogland, Michaela Gegusch, Johannes Slotboom, Yulia Worbe, Emmanuel Roze, Anke Scheel-Sailer, et al.

    Functional paralysis (FP), a subtype of functional neurological disorder (FND), is characterized by symptoms of paralysis without clinically evident damage to the nervous system. Previous research has reported impaired inhibitory control in FND, such as weaker inhibition and slower response latencies, yet the underlying neural correlates remain unclear. Moreover, it is unknown whether such neural correlates depend on the symptoms or are a specific trait of the disorder. To address this gap, we compared individuals with chronic FP, healthy controls (HCs) and individuals with spinal cord injury (SCI), who present a similar symptom phenotype but differ in the cause of their condition, hence provided the opportunity to disentangle disorder-specific from symptom-specific patterns of neural activity. In this observational study, 16 patients with FP (6 males/10 females; mean age = 39.4 ± 13.1 years), 24 patients with SCI (18 males/6 females; mean age = 42.4 ± 11.6 years) and 29 HC (8 males/21 females; mean age = 35.5 ± 12.6 years) underwent event-related functional MRI while performing a go/no-go task. We conducted a task-related validation analysis to isolate functional networks involved in response inhibition, and implemented a generalized psychophysiological interaction (gPPI) focusing on the associative motor network. We then compared behavioural performance and patterns of functional connectivity across groups with a general linear model. No group differences in task performance emerged, suggesting intact motor inhibition in FP. Validation analysis over the whole sample showed the recruitment of typical regions of the motor inhibition network. Compared with HC, we identified significant differences in functional connectivity (P < 0.05, family-wise error corrected) in both paralysis groups (FP and SCI), which exhibited higher functional connectivity between the right precentral gyrus and the left insula during response inhibition. Functional connectivity during response inhibition was similar between patient groups. These findings suggest a shared neural pattern associated with symptoms of paralysis, rather than a disorder-specific deficit, and may reflect an abnormal limbic drive of the motor network involved in movement initiation.


  • Top Cited Papers
    Open Access

    Towards fair decentralized benchmarking of healthcare AI algorithms with the Federated Tumor Segmentation (FeTS) challenge

    by Maximilian Zenk, Ujjwal Baid, Sarthak Pati, Akis Linardos, Brandon Edwards, Micah Sheller, Patrick Foley, Alejandro Aristizabal, David Zimmerer, Alexey Gruzdev, et al.

    Computational competitions are the standard for benchmarking medical image analysis algorithms, but they typically use small curated test datasets acquired at a few centers, leaving a gap to the reality of diverse multicentric patient data. To this end, the Federated Tumor Segmentation (FeTS) Challenge represents the paradigm for real-world algorithmic performance evaluation. The FeTS challenge is a competition to benchmark (i) federated learning aggregation algorithms and (ii) state-of-the-art segmentation algorithms, across multiple international sites. Weight aggregation and client selection techniques were compared using a multicentric brain tumor dataset in realistic federated learning simulations, yielding benefits for adaptive weight aggregation, and efficiency gains through client sampling. Quantitative performance evaluation of state-of-the-art segmentation algorithms on data distributed internationally across 32 institutions yielded good generalization on average, albeit the worst-case performance revealed data-specific modes of failure. Similar multi-site setups can help validate the real-world utility of healthcare AI algorithms in the future.


  • Open Access

    CHEmical-shift selective Adiabatic Pulse (CHEAP): Fast and High Resolution Downfield 3D 1H-MRSI at 7T

    by Guodong Weng, Piotr Radojewski, Sulaiman Sheriff, Arsany Hakim, Irena Zubak, Johannes Kaesmacher, Johannes Slotboom

    The key molecules such as triphosphate (ATP), glutathione (GSH), and homocarnosine (hCs) - central to metabolic processes in the human brain remain elusive or challenging to detect with upfield 1H-MRSI. Traditional 3D 1H-MRSI in vivo faces challenges, including a low signal-to-noise ratio and magnetization transfer effects with water, leading to prolonged measurement times and reduced resolution. To address these limitations, we propose a downfield 3D-MRSI method aimed at measuring downfield metabolites with enhanced spatial resolution, and speed acceptable for clinical practice at 7T. The CHEmical-shift selective Adiabatic Pulse (CHEAP) technique was integrated into echo-planar spectroscopic imaging (EPSI) readout sequence for downfield metabolite and water reference 3D-MRSI. Five healthy subjects and two glioma patients were scanned to test the feasibility. In this work, CHEAP-EPSI technique is shown to significantly enhance spatial the resolution to 0.37 ml while simultaneously reducing the scan time to 10.5 minutes. Its distinct advantages include low specific absorption rate, effective suppression of water and lipid signals, and minimal baseline distortions, making it a valuable tool for research or potentially diagnostic purposes. CHEAP-EPSI improves the detection sensitivity of downfield metabolites like N-acetyl-aspartate (NAA+) and DF8.18 (ATP&GSH+), and offers new possibilities for the study of metabolism in healthy and diseased brain.

  • Comparison of baseline correction algorithms for in vivo 1H‐MRS

    by Diego Pasmiño, Johannes Slotboom, Brigitte Schweisthal, Pamela Guevara, Waldo Valenzuela, Esteban J. Pino

    Proton MRS is used clinically to collect localized, quantitative metabolic data from living tissues. However, the presence of baselines in the spectra complicates accurate MRS data quantification. The occurrence of baselines is not specific to short‐echo‐time MRS data. In short‐echo‐time MRS, the baseline consists typically of a dominating macromolecular (MM) part, and can, depending on B0 shimming, poor voxel placement, and/or localization sequences, also contain broad water and lipid resonance components, indicated by broad components (BCs). In long‐echo‐time MRS, the MM part is usually much smaller, but BCs may still be present. The sum of MM and BCs is denoted by the baseline. Many algorithms have been proposed over the years to tackle these artefacts. A first approach is to identify the baseline itself in a preprocessing step, and a second approach is to model the baseline in the quantification of the MRS data themselves. This paper gives an overview of baseline handling algorithms and also proposes a new algorithm for baseline correction. A subset of suitable baseline removal algorithms were tested on in vivo MRSI data (semi‐LASER at TE = 40 ms) and compared with the new algorithm. The baselines in all datasets were removed using the different methods and subsequently fitted using spectrIm‐QMRS with a TDFDFit fitting model that contained only a metabolite basis set and lacked a baseline model. The same spectra were also fitted using a spectrIm‐QMRS model that explicitly models the metabolites and the baseline of the spectrum. The quantification results of the latter quantification were regarded as ground truth. The fit quality number (FQN) was used to assess baseline removal effectiveness, and correlations between metabolite peak areas and ground truth models were also examined. The results show a competitive performance of our new proposed algorithm, underscoring its automatic approach and efficiency. Nevertheless, none of the tested baseline correction methods achieved FQNs as good as the ground truth model. All separately applied baseline correction methods introduce a bias in the observed metabolite peak areas. We conclude that all baseline correction methods tested, when applied as a separate preprocessing step, yield poorer FQNs and biased quantification results. While they may enhance visual display, they are not advisable for use before spectral fitting.


  • Open Access

    TensorFit: A torch‐based tool for ultrafast metabolite fitting of large MRSI data sets

    by Federico Turco, Milena Capiglioni, Guodong Weng, Johannes Slotboom

    Purpose: To introduce a tool (TensorFit) for ultrafast and robust metabolite fitting of MRSI data based on Torch's auto‐differentiation and optimization framework.Methods: TensorFit was implemented in Python based on Torch's auto‐differentiation to fit individual metabolites in MRS spectra. The underlying time domain and/or frequency domain fitting model is based on a linear combination of metabolite spectroscopic response. The computational time efficiency and accuracy of TensorFit were tested on simulated and in vivo MRS data and compared against TDFDFit and QUEST.Results: TensorFit demonstrates a significant improvement in computation speed, achieving a 165‐times acceleration compared with TDFDFit and 115 times against QUEST. TensorFit showed smaller percentual errors on simulated data compared with TDFDFit and QUEST. When tested on in vivo data, it performed similarly to TDFDFit with a 2% better fit in terms of mean squared error while obtaining a 169‐fold speedup.Conclusion: TensorFit enables fast and robust metabolite fitting in large MRSI data sets compared with conventional metabolite fitting methods. This tool could boost the clinical applicability of large 3D MRSI by enabling the fitting of large MRSI data sets within computation times acceptable in a clinical environment.


  • Open Access

    Deep learning pipeline for quality filtering of MRSI spectra

    by Mladen Rakić, Federico Turco, Guodong Weng, Frederik Maes, Diana M. Sima, Johannes Slotboom

    With the rise of novel 3D magnetic resonance spectroscopy imaging (MRSI) acquisition protocols in clinical practice, which are capable of capturing a large number of spectra from a subject's brain, there is a need for an automated preprocessing pipeline that filters out bad‐quality spectra and identifies contaminated but salvageable spectra prior to the metabolite quantification step. This work introduces such a pipeline based on an ensemble of deep‐learning classifiers. The dataset consists of 36,338 spectra from one healthy subject and five brain tumor patients, acquired with an EPSI variant, which implemented a novel type of spectral editing named SLOtboom–Weng (SLOW) editing on a 7T MR scanner. The spectra were labeled manually by an expert into four classes of spectral quality as follows: (i) noise, (ii) spectra greatly influenced by lipid‐related artifacts (deemed not to contain clinical information), (iii) spectra containing metabolic information slightly contaminated by lipid signals, and (iv) good‐quality spectra.The AI model consists of three pairs of networks, each comprising a convolutional autoencoder and a multilayer perceptron network. In the classification step, the encoding half of the autoencoder is kept as a dimensionality reduction tool, while the fully connected layers are added to its output. Each of the three pairs of networks is trained on different representations of spectra (real, imaginary, or both), aiming at robust decision‐making. The final class is assigned via a majority voting scheme.The F1 scores obtained on the test dataset for the four previously defined classes are 0.96, 0.93, 0.82, and 0.90, respectively. The arguably lower value of 0.82 was reached for the least represented class of spectra mildly influenced by lipids.Not only does the proposed model minimise the required user interaction, but it also greatly reduces the computation time at the metabolite quantification step (by selecting a subset of spectra worth quantifying) and enforces the display of only clinically relevant information.


  • Open Access

    α-D-Glucose as a non-radioactive MRS tracer for metabolic studies of the brain

    by Guodong Weng, Piotr Radojewski, Johannes Slotboom

    Changes in brain glucose metabolism occur in many neurological disorders as well as during aging. Most studies on the uptake of glucose in the brain use positron emission tomography, which requires injection of a radioactive tracer. Our study shows that ultra-high-field 1H-MRS can be used to measure α-d-glucose at 5.22 ppm in vivo, and the α-d-glucose can be used as a radiation-free tracer in the human brain.